Managing Counterfeiting Issues in the Pharmaceutical Industry
Pharmaceutical counterfeiting poses a threat to consumers and harms both the reputation and financial condition of pharmaceutical companies. On Tuesday, June 18, the Gibbons Institute of Law, Science & Technology will be hosting “Managing Counterfeiting Issues in the Pharmaceutical Industry,” from 5:00 – 7:00 pm at Seton Hall Law School in Newark, NJ.
This program will identify practical, anti-counterfeiting strategies and discuss how drug companies can develop and implement tailored “best practices” to deter and combat counterfeiters.
Panelists for this program include:
- Catherine A. Begley, Regional Security Director for the North America Region, Merck
- Kathleen H. Dooley, Partner, McGuireWoods LLP
- Owen J. McKeon, Director, Intellectual Property Department, Gibbons P.C.
- David W. Opderbeck, Professor of Law and Director, Gibbons Institute of Law, Science & Technology
- Estelle J. Tsevdos, Ph.D., Director, Intellectual Property Department, Gibbons P.C.
The panelists will discuss the use of technology in inventory tracking and product authentication, various employee training programs that can help companies avoid counterfeiting and how to develop comprehensive investigative and enforcement strategies.
Registration for the program starts at 4:30 pm, with the panel discussion at 5:00 pm and a networking reception following the program at 7:00 pm. The $30 program fee includes food, beverages, parking and 2.0 NY & NJ CLE Credits.